Get started
Author

Divya Ravichandar

Observed name: D Ravichandar
Observed institution: Second Genome (United States)
ORCID: 0000-0002-2226-8652
Observed ORCID: 0000-0002-2226-8652
OpenAlex ID: A5068178540
StrainSelect: A novel microbiome reference database that disambiguates all bacterial strains, genome assemblies and extant cultures worldwide
2023 · Todd Z. DeSantis, Cesar Cardona, et al. · Heliyon · 9
DOP54 Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract
2022 · I Shilova, C La Chat, et al. · Journal of Crohn s and Colitis · 2
PDF
Abstract 6349: Targeting the CXCR3 pathway with a novel peptide drug candidate mobilizes the immune system to enhance anti-tumor immunity
2022 · Dhwani Haria, Jina Lee, et al. · Cancer Research
Abstract P260: Development and validation of a novel T-cell modulating, microbiome-based peptide for combination with immunotherapy
2021 · Michelle Lin, Archana S. Nagaraja, et al. · Molecular Cancer Therapeutics
Abstract B28: A novel intestinal microbiome-derived peptide modulates immune cell activity and the tumor microenvironment
2020 · Helena Kiefel, Dhwani Haria, et al. · Cancer Research
Abstract 4963: A novel intestinal microbiome-derived peptide modulates immune cell activity and the tumor microenvironment
2019 · Helena Kiefel, Dhwani Haria, et al. · Immunology
Abstract 4963: A novel intestinal microbiome-derived peptide modulates immune cell activity and the tumor microenvironment
2019 · Helena Kiefel, Dhwani Haria, et al. · Cancer Research
Works count: 7
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type